FRM
WST icon

Fox Run Management’s West Pharmaceutical WST Stock Holding History

Fox Run Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,055
Closed -$2.22M – 1343
2026
Q1 		$2.22M Buy
9,055
+5,261
+139% +$1.31M 0.39% 10
2025
Q4 		$1.04M Sell
3,794
-1,396
-27% -$382K 0.16% 197
2025
Q3 		$1.36M Sell
5,190
-2,504
-33% -$609K 0.21% 115
2025
Q2 		$1.68M Buy
+7,694
New +$1.64M 0.28% 58
2024
Q4 		– Sell
-1,112
Closed -$334K – 1215
2024
Q3 		$334K Sell
1,112
-2,112
-66% -$647K 0.07% 502
2024
Q2 		$1.06M Buy
+3,224
New +$1.14M 0.2% 161
2023
Q4 		– Sell
-2,470
Closed -$927K – 1057
2023
Q3 		$927K Buy
+2,470
New +$955K 0.27% 88
2023
Q1 		– Sell
-1,523
Closed -$358K – 961
2022
Q4 		$358K Buy
1,523
+613
+67% +$145K 0.14% 282
2022
Q3 		$224K Buy
+910
New +$277K 0.09% 447
2021
Q4 		– Sell
-530
Closed -$225K – 731
2021
Q3 		$225K Buy
+530
New +$223K 0.14% 341
2019
Q4 		– Sell
-5,136
Closed -$728K – 549
2019
Q3 		$728K Buy
+5,136
New +$707K 0.66% 7
2019
Q1 		– Sell
-4,385
Closed -$430K – 719
2018
Q4 		$430K Buy
+4,385
New +$476K 0.23% 153
2017
Q4 		– Sell
-5,200
Closed -$501K – 917
2017
Q3 		$501K Sell
5,200
-4,100
-44% -$371K 0.14% 297
2017
Q2 		$879K Buy
+9,300
New +$855K 0.3% 59

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fox Run Management's WST Position: Q2 2026 in Review

Fox Run Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 9,055 shares — an estimated $2.22M sold.

Fox Run Management first reported a position in WST in Q2 2017 and held it in 14 quarters. The position peaked at $2.22M in Q1 2026. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fox Run Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 9,055 West Pharmaceutical shares in Q2 2026, an estimated $2.22M.
  • Fox Run Management first reported a position in West Pharmaceutical in Q2 2017 and held it in 14 quarters.
  • Fox Run Management's West Pharmaceutical position peaked at $2.22M in Q1 2026.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.